Illumina, Inc. (Nasdaq: ILMN) today announced an agreement with the Institute of Medical Genetics and Applied Genomics at the University Hospital of Tübingen to assess the value of whole-genome sequencing (WGS) as a first-line diagnostic test for patients with genetic diseases and familial cancer syndromes. Illumina will support the new investigator-initiated study, called the Ge-Med […]
Partner program designed to advance Sample to Insight solutions from research to patients leveraging QIAGEN’s unique Knowledge Base Five initial partners sign with QIAGEN Digital Insights (QDI) to grow QIAGENs unique genomic Knowledge Base and accelerate access New partnerships to deliver improved AI services and databases in oncology, secondary analysis and combined NGS panels and […]
Parse Biosciences (https://www.parsebiosciences.com/), a company providing researchers with scalable and flexible single-cell sequencing solutions, announced the launch of its Single Cell Whole Transcriptome Kit. The kit, which was previously available only through Parse’s early-access program, is now generally available to all researchers in North America. The Whole Transcriptome Kit from Parse Biosciences contains everything needed […]
MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leading provider of high-quality, long-read sequencing platforms, today announced that Labcorp (NYSE: LH), a leading global life sciences company, has increased its commitment to highly accurate HiFi sequencing with the addition of new PacBio® Sequel® II Systems. The new systems will expand Labcorp’s capacity to […]
– Focus on Rare Disease Prenatal and Pediatric Genetic Screening Services – SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Victorian Clinical Genetic Services (VCGS), an Australian-based specialist provider of prenatal, childhood and adult genetics […]
LUXEMBOURG — Eurofins adds today virus variant monitoring capabilities to its commercially available SARS-CoV-2 stand-alone test kit portfolio. This new solution is also part of the Eurofins Covid-19 Sentinel™ and the SAFER@WORK™ program which provide an early warning of the presence of SARS-CoV-2 amongst large populations at a given site (e.g. a city, factories, education institutions, […]
ZeClinics is applying CRISPR technology to create gene edited zebrafish disease models Dublin, Ireland & Barcelona, Spain: ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and ZeClinics, a contract research organization using zebrafish to carry out services focused on analyzing the safety, efficacy […]
VISBEK, Germany and CAMARILLO, Calif. — EW GROUP, a German strategic holding company in the field of animal breeding, health, nutrition and diagnostics, announced today the acquisition of Hygiena, a leader in food safety and environmental testing solutions. The terms of the transaction have not been disclosed. The transaction is expected to close in March 2021. Hygiena, headquartered in Camarillo, […]
The ForenSeq Kintelligence Kit, in conjunction with GEDmatch PRO, provides a fit-for-forensic-purpose genetic genealogy workflow that generates investigative leads, minimizes privacy concerns, and maintains chain of custody. SAN DIEGO, CA. — Verogen Inc. announced today that it is expanding capabilities for the NDIS-approved MiSeq FGx Sequencing System with the commercial launch of the ForenSeq Kintelligence […]
LONGMONT, Colo. — KromaTiD is pleased to announce that Colorado biomedical entrepreneur James Chomas has joined the company’s Board of Directors. Jim has a track record of developing innovative healthcare solutions and driving adoption by customers and strategic partners. KromaTiD’s sales and operations are rapidly accelerating and Jim’s deep experience in healthcare product definition, commercialization, and organizational growth bring […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
